A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...